Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105802

The role of sodium in intestinal glucose absorption in man

Ward A. Olsen and Franz J. Ingelfinger

Evans Memorial Department of Clinical Research, University Hospital, Boston City Hospital, Boston, Massachusetts 02118

Department of Medicine, Boston University School of Medicine, Boston University Medical Center, and the 5th and 6th Medical Services (Boston University), Boston City Hospital, Boston, Massachusetts 02118

Find articles by Olsen, W. in: JCI | PubMed | Google Scholar

Evans Memorial Department of Clinical Research, University Hospital, Boston City Hospital, Boston, Massachusetts 02118

Department of Medicine, Boston University School of Medicine, Boston University Medical Center, and the 5th and 6th Medical Services (Boston University), Boston City Hospital, Boston, Massachusetts 02118

Find articles by Ingelfinger, F. in: JCI | PubMed | Google Scholar

Published May 1, 1968 - More info

Published in Volume 47, Issue 5 on May 1, 1968
J Clin Invest. 1968;47(5):1133–1142. https://doi.org/10.1172/JCI105802.
© 1968 The American Society for Clinical Investigation
Published May 1, 1968 - Version history
View PDF
Abstract

The effect of luminal sodium on intestinal glucose absorption at a variety of glucose concentrations was studied with a segmental perfusion technique in normal subjects.

Uphill glucose transport was inhibited with sodium-free perfusions with either mannitol or Tris-HCl as the osmotic replacement of sodium (P < 0.01-P < 0.001). This effect did not appear to be the result of solvent drag, as increasing net water absorption without supplying sodium to the lumen did not increase glucose absorption.

Downhill glucose transport (infusion concentrations of 6.0-27.8 mmoles/liter), on the other hand, was not affected by the absence of sodium in the infusion solution.

Glucose concentrations of upper intestinal fluid after normal carbohydrate meals were usually found to exceed serum concentrations; thus, downhill glucose absorption, with, at most, a very limited dependence upon intraluminal sodium concentration, may account for a significant part of normal carbohydrate absorption.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1133
page 1133
icon of scanned page 1134
page 1134
icon of scanned page 1135
page 1135
icon of scanned page 1136
page 1136
icon of scanned page 1137
page 1137
icon of scanned page 1138
page 1138
icon of scanned page 1139
page 1139
icon of scanned page 1140
page 1140
icon of scanned page 1141
page 1141
icon of scanned page 1142
page 1142
Version history
  • Version 1 (May 1, 1968): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts